Application of single nucleotide polymorphism array in prenatal diagnosis for fetuses with abnormal ultrasound findings
- Author:
- No author available
- Journal Title:
- Chinese Journal of Obstetrics and Gynecology
- Issue:
- 7
- DOI:
- 10.3760/cma.j.issn.0529-567x.2018.07.005
- Key Word:
- 先天畸形;染色体畸变;多态性,单核苷酸;核型分析;超声检查,产前
Abstract： 目的 分析单核苷酸多态性芯片(SNP-array)技术在超声检查异常胎儿产前诊断中的应用价值.方法 收集2015年5月至2017年11月于郑州大学第一附属医院就诊、产前超声检查结果异常的胎儿共904例.904例胎儿均接受SNP-array技术检测,其中434例(48.0％,434/904)同时行染色体核型分析.904例胎儿根据异常的超声检查结果类型分为5组:单结构畸形组280例(31.0％),多结构畸形组31例(3.4％),单软指标异常组331例(36.6％),多软指标异常组107例(11.8％),结构畸形合并软指标异常组155例(17.2％),比较5组超声检查异常胎儿的染色体异常率.结果 (1)总体SNP-array结果:904例胎儿中,SNP-array技术检出染色体异常率18.9％(171/904),发现致病性拷贝数变异(pCNV)27例(3.0％,27/904),临床意义不明确的拷贝数变异(VOUS)71例(7.9％,71/904).对27例携带VOUS的胎儿进行父母验证,发现7例(26.0％,7/27)为新发突变.(2)5组超声检查异常胎儿的SNP-array结果:单结构畸形组检出染色体异常率为19.3％(54/280)、多结构畸形组为25.8％(8/31)、单软指标异常组为13.9％(46/331)、多软指标异常组为19.6％(21/107)、结构畸形合并软指标异常组为27.1％(42/155),5组比较,差异有统计学意义(P=0.010);在单软指标异常组胎儿中,脉络丛囊肿、心室强光点、单脐动脉和肾盂增宽者均未检出染色体异常.(3)超声检查异常胎儿检出染色体非整倍体异常率随孕妇年龄增加而升高,但其随孕周的增加而降低(P均<0.05);而超声检查异常胎儿pCNV和VOUS的检出率,不随孕妇年龄及孕周的改变而变化(P均>0.05).(4)SNP-array与染色体核型分析结果的比较:904例胎儿中,434例胎儿同时接受了染色体核型分析和SNP-array检测,染色体核型分析检出胎儿染色体异常率10.3％(43/419),SNP-array检出胎儿染色体异常率18.7％(81/434).结论SNP-array可作为产前超声检查异常胎儿遗传学诊断的有效方法.对于不同种类的产前超声检查异常胎儿,SNP-array检出的染色体异常率不同.与染色体核型分析比较,SNP-array技术可提高产前超声检查异常胎儿的染色体异常检出率,且能够发现染色体核型分析不能检出的染色体异常,为妊娠提供更合理的建议.
- [1]贾静,何梦舟,张婧怡,等.单亲二倍体染色体异常的研究进展[J].2017,(5).
- [2]吴轲,唐少华,陈冲,等.产前超声异常胎儿的全基因组拷贝数变异分析[J].2017,(2).
- [3]Ronald I. Wapner,Christa Lese Martin,Brynn Levy,etc.Chromosomal Microarray versus Karyotyping for Prenatal Diagnosis[J].2012,367(23).
- [4]Hixson,P.,Lupski,J.R.,Ward,P.,etc.Prenatal chromosomal microarray analysis in a diagnostic laboratory; experience with>1000 cases and review of the literature[J].2012,32(4).
- [5]Norton, Mary E.,Jackson, Marc.Prenatal Diagnostic Testing for Genetic Disorders[J].2016,127(5).
- [6]王敏,王昊,梅瑾,等.染色体不平衡易位的产前诊断与遗传学研究[J].2018,(1).
- [7]S C Hillman,D J McMullan,G Hall,etc.Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis.[J].2013,41(6).
- [8].Meiotic origins of maternal age-related aneuploidy[J].2012,86(1).
- [9]Coppinger J,Alliman S,Lamb A.Whole-genome microarray analysis in prenatal specimens identifies clinically significant chromosome alterations without increase in results of unclear significance compared to targeted microarray.[J].2009,29(12).
- [10]Eric Engel.A new genetic concept: Uniparental disomy and its potential effect, isodisomy[J].1980,6(2).
- [11]Kearney HM,Thorland EC,Brown KK,etc.American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants.[J].2011,13(7).
- [12]de Vries, Femke A. T.,de Wit, Merel C.,Govaerts, Lutgarde C. P.,etc.Prenatal SNP array testing in 1000 fetuses with ultrasound anomalies: causative, unexpected and susceptibility CNVs[J].2016,24(5).
- [13]S, Pathak,C, Lees.Ultrasound structural fetal anomaly screening: an update.[J].2009,94(5).
- [14]Dugoff, Lorraine,Norton, Mary E.,Kuller, Jeffrey A..The use of chromosomal microarray for prenatal diagnosis[J].2016,215(4).
- [15]Torchia,B.S.,Bandholz,A.M.,Dabell,M.P.,etc.Detection rates of clinically significant genomic alterations by microarray analysis for specific anomalies detected by ultrasound[J].2012,32(10).
- [16]Yatsenko,S.,Emery,S.,Clemens,M.,etc.Application of chromosomal microarray in the evaluation of abnormal prenatal findings[J].2013,84(1).
- [17].Committee opinion no. 581: the use of chromosomal microarray analysis in prenatal diagnosis.[J].2013,122(6).